Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zaleha Abdullah Mahdy is active.

Publication


Featured researches published by Zaleha Abdullah Mahdy.


British Journal of Obstetrics and Gynaecology | 2005

Risk factors associated with subaponeurotic haemorrhage in full‐term infants exposed to vacuum extraction

Nem Yun Boo; Kin Wai Foong; Zaleha Abdullah Mahdy; Sin Chuen Yong; Rohana Jaafar

Objectives  To determine obstetric and neonatal risk factors associated with subaponeurotic haemorrhage (SAH) in infants exposed to vacuum extraction.


International Journal of Gynecology & Obstetrics | 2001

Risk factor screening for abnormal glucose tolerance in pregnancy

K. Shamsuddin; Zaleha Abdullah Mahdy; I. Siti Rafiaah; M.A. Jamil; M.D. Rahimah

Objectives: To assess the prevalence and association of frequently used screening risk factors for gestational diabetes mellitus (GDM) and to compare the validity and cost of universal screening with risk factor screening. Method: A cross‐sectional survey of 768 pregnant women at ≥24 weeks’ gestation who were attending the antenatal clinic at the Hospital Universiti Kebangsaan Malaysia (HUKM) was made. Risk factors were determined using a questionnaire. An abnormal oral glucose tolerance test was defined as a 2‐h post‐prandial blood sugar level of ≥7.8 mmol/l. Results: A total of 191 pregnant mothers (24.9%) had GDM. The most commonly identified screening factors were positive family history of diabetes mellitus (31.4%), history of spontaneous abortion (17.8%), vaginal discharge and pruritis vulvae in current pregnancy (16.0%), and maternal age greater than 35 years (14.7%). Five hundred and thirteen mothers (66.8%) had at least one risk factor. All screening risk factors, except past history of diabetes mellitus in previous pregnancy and maternal age, were not significantly associated with abnormal glucose tolerance (GT). Risk factor screening gave a sensitivity of 72.2% and a specificity of 35.0%. Universal screening would cost RM 12.06 while traditional risk factor screening would cost RM 11.15 per identified case and will have missed 53 of the 191 cases. Conclusions: Risk factor screening scored poorly in predicting GDM. Cost analysis of universal compared with traditional risk factor screening showed a negligible difference. Thus universal screening appears to be the most reliable method of diagnosing GDM.


Australian & New Zealand Journal of Obstetrics & Gynaecology | 2007

The Vabra aspirator versus the Pipelle device for outpatient endometrial sampling.

Norzilawati Mohd Naim; Zaleha Abdullah Mahdy; Shuhaila Ahmad; Zainul Rashid Mohd Razi

Objective:  To compare the effectiveness of the Vabra aspirator and the Pipelle device as an outpatient endometrial assessment tool.


International Journal of Gynecology & Obstetrics | 2005

Tocolysis in term breech external cephalic version

M. I. Nor Azlin; H. Haliza; Zaleha Abdullah Mahdy; I. Anson; M.N. Fahya; Muhammad Abdul Jamil

To study the effect of ritodrine tocolysis on the success of external cephalic version (ECV) and to assess the role of ECV in breech presentation at our centre.


Journal of Obstetrics and Gynaecology | 2008

The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial.

M. I. Nor Azlin; I. Maryasalwati; M. N. Norzilawati; Zaleha Abdullah Mahdy; Muhammad Abdul Jamil; M. R. Zainul Rashid

Summary Dysmenorrhoea is painful menstruation that occurs in 45–72% of all women. This was a prospective randomised study of the efficacy of etoricoxib (Arcoxia®) compared with mefenamic acid (Ponstan®) in treating primary dysmenorrhoea. All single, sexually inactive women with primary dysmenorrhoea were randomised into two groups (mefenamic acid and etoricoxib) of pain relief and underwent a cross-over study. The success of treatment as evidenced by pain relief, the side-effects and complications were observed and analysed. Some 80% (20 women) had significantly better pain relief with etoricoxib, compared with only 20 per cent in the mefenamic acid group (p = 0.007). Etoricoxib has significantly fewer side-effects compared with mefenamic acid (p = 0.005) with significantly reduced menstrual blood loss (p = 0.025). In conclusion, etoricoxib is a better treatment for primary dysmenorrhoea with better pain relief, less menstrual blood loss and fewer side-effects compared with mefenamic acid.


Journal of Obstetrics and Gynaecology Research | 2012

Effects of preeclampsia on the yield of hematopoietic stem cells obtained from umbilical cord blood at delivery.

Fadilah S. Abdul Wahid; Mona Zaria Nasaruddin; Mohd Razif Mohd Idris; Maiza Tusimin; Nor Rafeah Tumian; Zaleha Abdullah Mahdy

Aim:  To compare the numbers of cord blood CD34+ hematopoietic stem cells (HSC) between preeclampsia (PE) and control (non‐PE) subjects and to determine the factors that may influence this observation.


Acta Medica (Hradec Kralove, Czech Republic) | 2011

GESTATIONAL DIABETES MELLITUS IN PRIMIGRAVIDAE: A MILD DISEASE

Nor Azlin Mohamed Ismail; Norkhatijah Mohd Aris; Zaleha Abdullah Mahdy; Shuhaila Ahmad; Norzilawati Mohd Naim; Harlina Harlizah Siraj; Syed Zulkifli Syed Zakaria

This prospective observational study was done to analyse the prevalence of gestational diabetes mellitus (GDM) among primigravidae and its outcome. All healthy primigravidae with singleton pregnancies were offered universal glucose tolerance testing between 16 and 28 weeks gestation. GDM and non GDM groups were managed according to hospital protocol. The antenatal features and pregnancy outcomes were analysed. Out of 616 primigravidae, 113 (18.34%) were GDM with slightly older (27.9 +/- 4.2 versus 26.32 +/- 3.3, p < 0.001) age. The mean fasting and two hours postprandial blood glucose in both groups were 4.99 +/- 1.08 mmol/l, 8.86 +/- 1.41 mmol/l(GDM) and 4.36 +/- 0.43 mmol/l, 5.71 +/- 1.11 mmol/l (Non GDM), respectively. Maternal family history of diabetes mellitus, weight exceeding 80 Kg, polyhydramnios (2.65% versus 0.2%, p = 0.028) and neonatal hyperbilirubinaemia (9.73% versus 2.98%, p = 0.01) occurred significantly more frequent in the GDM group compared to normal. There was no significant difference in other pregnancy outcomes and complications between the two groups. In conclusion GDM in primigravidae was detected at a relatively young age with more frequent maternal family history of DM, weight exceeding 80 Kg, polyhydromnions and neonatal hyperbilirubinaemia. The degree of disease was mild and treatment led to no significant complication.


British Journal of Obstetrics and Gynaecology | 2016

Nifedipine maintenance tocolysis and perinatal outcome: an individual participant data meta-analysis

Eog van Vliet; Gh Dijkema; Ewoud Schuit; Karst Y. Heida; Carolien Roos; Jam van der Post; Emma Parry; Lesley McCowan; Dj Lyell; Yasser Y. El-Sayed; Db Carr; Al Clark; Zaleha Abdullah Mahdy; M. Uma; Nc Sayin; Gf Varol; B.W. Mol; M.A. Oudijk

Preterm birth is the leading cause of neonatal mortality and morbidity in developed countries. Whether continued tocolysis after 48 hours of rescue tocolysis improves neonatal outcome is unproven.


Obstetrics & Gynecology | 2008

Advanced abdominal pregnancy resulting from late uterine rupture.

Norzilawati Mohd Naim; Shuhaila Ahmad; Harlina Halizah Siraj; Paul Ng; Zaleha Abdullah Mahdy; Zainul Rashid Mohd Razi

BACKGROUND: Advanced abdominal pregnancy is rare, and one that occurs after uterine rupture with delivery of a viable fetus is exceptional. CASE: A multiparous patient was admitted at 29 weeks of gestation for conservative management of placenta previa. She complained of intermittent abdominal pain, but repeated assessment suggested that both the patient and the fetus were doing well. At 36 weeks, an abdominal pregnancy was diagnosed with radiological features suggestive of uterine rupture. Laparotomy was performed and a healthy infant was delivered. CONCLUSION: Fetal viability was achieved in this case of abdominal pregnancy secondary to uterine rupture after close maternal and fetal surveillance.


International Journal of Gynecology & Obstetrics | 2008

Nifedipine versus terbutaline for tocolysis in external cephalic version

Nor Azlin Mohamed Ismail; Maryasalwati Ibrahim; Norzilawati Mohd Naim; Zaleha Abdullah Mahdy; Mohammad Abdul Jamil; Zainul Rashid Mohd Razi

To study the efficacy of nifedipine compared with terbutaline as a tocolytic agent in external cephalic version (ECV).

Collaboration


Dive into the Zaleha Abdullah Mahdy's collaboration.

Top Co-Authors

Avatar

Shuhaila Ahmad

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Khadijah Shamsuddin

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Harlina Halizah Siraj

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Nor Azlin Mohamed Ismail

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Norzilawati Mohd Naim

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Muhammad Abdul Jamil

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Rohana Jaafar

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Zaleha Md Isa

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Ani Amelia Zainuddin

National University of Malaysia

View shared research outputs
Top Co-Authors

Avatar

Nabishah Mohamad

National University of Malaysia

View shared research outputs
Researchain Logo
Decentralizing Knowledge